Role of Linkus as an antitussive and expectorative herbal preparation in patients with cough syndrome
It has been clinically proven that Linkus is a safe and effective antitussive and expectorative medicinal preparation for patients with cough syndrome at the background of acute inflammatory diseases of upper lower respiratory tracts and in chronic nonspecific broncholithic pathology.
Conducted by Russian Academy of Medical Sciences in Moscow by Professor Kukes V. G. from Dec 1999 to Feb 2000.
Usage of Linkus Syrup is an ultimate cure for children with acute viral disorders under 3 years
It has been clinically proven that Linkus is safe and effective in treating acute viral and bacterial disorders of respiratory organs in children of age 3 years and below. Its overall efficacy rate is 96.6% and overall acceptable tolerability rate is 100% in children.
Conducted by Moscow Scientific Research Institute of Pediatrics and Children’s surgery by Professor A.D. Tsaregorodtsev in 2004 .
Safety and Effectiveness of Linkus Syrup in Acute Respiratory Viral Infection (ARVI)
It has been clinically proven that Linkus is a safe and effective herbal remedy in treating ARVI (pharyngitis, nazopharyngitis, pharyngotracheitis, tracheitis and bronchitis). Its overall acceptable tolerability rate is 88.5%.
Conducted by Public Health Authorities of Perm by S.E. Nadymova, N.A. Krasavina, and A.V. Kruten at City children’s clinical hospital in 2002.
Tolerability of Linkus preparation in children with Bronchopulmonary Pathology
It has been clinically proven that Linkus is safe and effective in treating children with bronchopulmonary pathology (acute bronchitis and bronchopneumonia). It effectively reduces intensity of cough syndrome, facilitates phlegm emission from the first day of administration and considerably reduces intoxication symptoms (hyperthermia, sweating, and weakness). Its overall efficacy rate is 81%.
Conducted by Almaty Public Health Services Department, Municipal State Enterprise by Head Physician I.V.Brezhneva in 2004.
